product summary
Loading...
company name :
BioLegend
other brands :
Babco, Signet, Sternberger Monoclonals, Senetek, Covance
product type :
protein
product name :
Recombinant Human M-CSF (carrier-free)
catalog :
574802
quantity :
10 μg
price :
112 USD
more info or order :
citations: 33
Reference
Hong Y, Dong X, Chang L, Xie C, Chang M, Aguilar J, et al. Microglia-containing cerebral organoids derived from induced pluripotent stem cells for the study of neurological diseases. iScience. 2023;26:106267 pubmed publisher
Mirji G, Worth A, Bhat S, El Sayed M, Kannan T, Goldman A, et al. The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer. Sci Immunol. 2022;7:eabn0704 pubmed publisher
Dahal S, Clayton K, Been T, Fernet Brochu R, Ocando A, Balachandran A, et al. Opposing roles of CLK SR kinases in controlling HIV-1 gene expression and latency. Retrovirology. 2022;19:18 pubmed publisher
Yamaguchi Y, Gibson J, Ou K, Lopez L, Ng R, Leggett N, et al. PD-L1 blockade restores CAR T cell activity through IFN-γ-regulation of CD163+ M2 macrophages. J Immunother Cancer. 2022;10: pubmed publisher
Nilsson A, Peters J, Meimetis N, Bryson B, Lauffenburger D. Artificial neural networks enable genome-scale simulations of intracellular signaling. Nat Commun. 2022;13:3069 pubmed publisher
Xiang J, Lu M, Shi M, Cheng X, Kwakwa K, Davis J, et al. Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19. J Virol. 2022;96:e0005722 pubmed publisher
Miyamoto T, Murakami R, Hamanishi J, Tanigaki K, Hosoe Y, Mise N, et al. B7-H3 Suppresses Antitumor Immunity via the CCL2-CCR2-M2 Macrophage Axis and Contributes to Ovarian Cancer Progression. Cancer Immunol Res. 2022;10:56-69 pubmed publisher
Zhai K, Huang Z, Huang Q, Tao W, Fang X, Zhang A, et al. Pharmacological inhibition of BACE1 suppresses glioblastoma growth by stimulating macrophage phagocytosis of tumor cells. Nat Cancer. 2021;2:1136-1151 pubmed publisher
Kuniholm J, Armstrong E, Bernabe B, Coote C, Berenson A, Patalano S, et al. Intragenic proviral elements support transcription of defective HIV-1 proviruses. PLoS Pathog. 2021;17:e1009982 pubmed publisher
Stephens W, Kubinak J, Ghazaryan A, Bauer K, Bell R, Buhrke K, et al. Epithelial-myeloid exchange of MHC class II constrains immunity and microbiota composition. Cell Rep. 2021;37:109916 pubmed publisher
Lecker L, Berlato C, Maniati E, Delaine Smith R, Pearce O, Heath O, et al. TGFBI Production by Macrophages Contributes to an Immunosuppressive Microenvironment in Ovarian Cancer. Cancer Res. 2021;81:5706-5719 pubmed publisher
Cordido A, Nu xf1 ez Gonzalez L, Martinez Moreno J, Lamas González O, Rodríguez Osorio L, Perez Gomez M, et al. TWEAK Signaling Pathway Blockade Slows Cyst Growth and Disease Progression in Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol. 2021;32:1913-1932 pubmed publisher
Yang F, He Z, Duan H, Zhang D, Li J, Yang H, et al. Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40. Nat Commun. 2021;12:3424 pubmed publisher
Virtakoivu R, Rannikko J, Viitala M, Vaura F, Takeda A, L xf6 nnberg T, et al. Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial. Clin Cancer Res. 2021;27:4205-4220 pubmed publisher
Heath O, Berlato C, Maniati E, Lakhani A, Pegrum C, Kotantaki P, et al. Chemotherapy Induces Tumor-Associated Macrophages that Aid Adaptive Immune Responses in Ovarian Cancer. Cancer Immunol Res. 2021;9:665-681 pubmed publisher
Sandstrom T, Ranganath N, Burke Schinkel S, Salahuddin S, Meziane O, C xf4 t xe9 S, et al. HIV-Infected Macrophages Are Infected and Killed by the Interferon-Sensitive Rhabdovirus MG1. J Virol. 2021;95: pubmed publisher
Chen X, Gao A, Zhang F, Yang Z, Wang S, Fang Y, et al. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation. Theranostics. 2021;11:3392-3416 pubmed publisher
Trapecar M, Wogram E, Svoboda D, Communal C, Omer A, Lungjangwa T, et al. Human physiomimetic model integrating microphysiological systems of the gut, liver, and brain for studies of neurodegenerative diseases. Sci Adv. 2021;7: pubmed publisher
Rexach J, Polioudakis D, Yin A, Swarup V, Chang T, Nguyen T, et al. Tau Pathology Drives Dementia Risk-Associated Gene Networks toward Chronic Inflammatory States and Immunosuppression. Cell Rep. 2020;33:108398 pubmed publisher
Walter F, Winter E, Rahn S, Heidland J, Meier S, Struzek A, et al. Chitosan nanoparticles as antigen vehicles to induce effective tumor specific T cell responses. PLoS ONE. 2020;15:e0239369 pubmed publisher
Lin H, Ji D, Lucherelli M, Reina G, Ippolito S, Samor xec P, et al. Comparative Effects of Graphene and Molybdenum Disulfide on Human Macrophage Toxicity. Small. 2020;16:e2002194 pubmed publisher
Heim C, Bosch M, Yamada K, Aldrich A, Chaudhari S, Klinkebiel D, et al. Lactate production by Staphylococcus aureus biofilm inhibits HDAC11 to reprogramme the host immune response during persistent infection. Nat Microbiol. 2020;5:1271-1284 pubmed publisher
Nenasheva T, Gerasimova T, Serdyuk Y, Grigor eva E, Kosmiadi G, Nikolaev A, et al. Macrophages Derived From Human Induced Pluripotent Stem Cells Are Low-Activated "Naïve-Like" Cells Capable of Restricting Mycobacteria Growth. Front Immunol. 2020;11:1016 pubmed publisher
Brasil da Costa F, Lewis M, Truong A, Carson D, Farach Carson M. SULF1 suppresses Wnt3A-driven growth of bone metastatic prostate cancer in perlecan-modified 3D cancer-stroma-macrophage triculture models. PLoS ONE. 2020;15:e0230354 pubmed publisher
Lu Y, Basatemur G, Scott I, Chiarugi D, Clement M, Harrison J, et al. Interleukin-33 Signaling Controls the Development of Iron-Recycling Macrophages. Immunity. 2020;52:782-793.e5 pubmed publisher
Yamada K, Heim C, Xi X, Attri K, Wang D, Zhang W, et al. Monocyte metabolic reprogramming promotes pro-inflammatory activity and Staphylococcus aureus biofilm clearance. PLoS Pathog. 2020;16:e1008354 pubmed publisher
Tsuchiya N, Zhang R, Iwama T, Ueda N, Liu T, Tatsumi M, et al. Type I Interferon Delivery by iPSC-Derived Myeloid Cells Elicits Antitumor Immunity via XCR1+ Dendritic Cells. Cell Rep. 2019;29:162-175.e9 pubmed publisher
Goel P, Egol A, Moharrer Y, Brandfield Harvey B, Ahn J, Ashley J. Notch signaling inhibition protects against LPS mediated osteolysis. Biochem Biophys Res Commun. 2019;: pubmed publisher
Cassetta L, Fragkogianni S, Sims A, Swierczak A, Forrester L, Zhang H, et al. Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets. Cancer Cell. 2019;35:588-602.e10 pubmed publisher
Thi Tran U, Kitami T. Niclosamide activates the NLRP3 inflammasome by intracellular acidification and mitochondrial inhibition. Commun Biol. 2019;2:2 pubmed publisher
Anantpadma M, Kouznetsova J, Wang H, Huang R, Kolokoltsov A, Guha R, et al. Large-Scale Screening and Identification of Novel Ebola Virus and Marburg Virus Entry Inhibitors. Antimicrob Agents Chemother. 2016;60:4471-81 pubmed publisher
Nijaguna M, Patil V, Urbach S, Shwetha S, Sravani K, Hegde A, et al. Glioblastoma-derived Macrophage Colony-stimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding Protein 1 (IGFBP1) to Promote Angiogenesis. J Biol Chem. 2015;290:23401-15 pubmed publisher
Lou J, Low Nam S, Kerkvliet J, Hoppe A. Delivery of CSF-1R to the lumen of macropinosomes promotes its destruction in macrophages. J Cell Sci. 2014;127:5228-39 pubmed publisher
product information
Antigen :
M-CSF
Apps. Abbrev. :
BA
Cat # :
574802
Item :
Recombinant Human M-CSF (carrier-free)
Other Names :
CSF1, CSF-1, MCSF
Size :
10 μg
Price (USD) :
112 USD
Reactivity :
Human
Host :
ADD EXPRESSION SYSTEM HERE
Conjugate/Tag/Label :
RECOM
Application Notes :
BioLegend carrier-free recombinant proteins provided in liquid format are shipped on blue-ice. Our comparison testing data indicates that when handled and stored as recommended, the liquid format has equal or better stability and shelf-life compared to commercially available lyophilized proteins after reconstitution. Our liquid proteins are verified in-house to maintain activity after shipping on blue ice and are backed by our 100% satisfaction guarantee. If you have any concerns, contact us at tech@biolegend.com.;
more info or order :
company information
BioLegend
8999 BioLegend Way
San Diego, CA 92121
customerserv@biolegend.com
https://www.biolegend.com
headquarters: USA